This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

21 Feb 2011

Bayer to Maintain 2012 R&D Budget at $4B

German drugmaker Bayer aims to invest around $4.07 billion into R&D in the current year; and for 2012, investments of a comparable level are planned, as newspaper reports.

The business newspaper Financial Times Deutschland reports that Bayer's internal papers indicate the German pharma giant will maintain its investment in R&D at just above $4 billion in 2012, keeping it match with the 2011 budget. The bulk of that money is devoted to healthcare, with about a third of the cash earmarked for crop and material science.


Related News